Humacyte Inc

Healthcare · Biotechnology

0.50$ -4.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Humacyte Inc (HUMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 138 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HUMA
Line item	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	169	–	0.1	101	107	112	96	303	287	264	246	226	204	183	168	149	128	161	138	115	138	163	139	92	116	111	138
Current Assets	95	94	–	1.3	41	46	31	244	229	209	193	175	154	134	121	103	83	118	96	23	48	74	52	41	68	64	93
Cash	94	94	–	1.3	40	45	29	240	218	198	181	164	150	130	115	100	80	116	94	21	45	63	38	19	50	49	80
Cash & Short-Term Investments	94	94	–	1.3	40	45	29	240	226	206	189	172	152	132	115	100	80	116	94	21	45	63	38	19	50	49	80
Receivables	0.6	–	–	–	0.1	0.2	0.7	0.2	0.2	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	0.0	0.5	0.4	1.1	0.4	0.4	0.3
Inventory	–	–	–	–	101	–	–	–	–	–	–	–	0.0	–	–	–	–	–	–	–	0.0	8.0	11	18	14	9.9	7.0
Property, Plant & Equipment	–	–	–	–	–	63	61	59	35	34	53	31	30	30	29	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	36	-132	0.1	2.0	36	56	54	228	164	161	104	108	87	101	107	112	115	135	167	178	191	127	135	96	113	99	107
Current Liabilities	11	–	0.1	0.1	11	15	16	21	11	11	11	18	20	24	11	15	18	14	18	21	20	20	21	26	18	16	15
Short-Term Debt	3.1	–	0.0	0.1	4.2	4.9	4.1	5.8	2.0	2.1	2.2	6.5	11	15	2.5	2.5	2.6	2.7	2.8	2.9	2.9	3.0	5.2	2.7	2.4	2.4	1.5
Accounts Payable	3.3	–	–	0.0	2.3	2.9	3.0	5.8	2.1	3.0	2.5	3.3	1.6	2.0	2.4	3.0	6.5	3.5	6.0	6.9	4.5	5.6	6.6	9.6	5.4	5.1	4.2
Long-Term Debt	–	–	–	–	–	–	15	14	27	28	28	24	20	16	36	37	39	–	–	–	–	–	–	–	35	36	36
Shareholders' Equity	132	132	0.0	99	71	55	41	76	122	104	142	119	117	82	61	37	14	26	-28	-64	-53	36	4.1	-4.8	3.1	12	31
Retained Earnings	-322	–	0.0	0.0	-388	-408	-426	-457	-415	-434	-398	-423	-427	-464	-486	-512	-537	-569	-626	-665	-686	-647	-685	-702	-727	-744	-781
Shares Outstanding	–	103	103	103	103	103	103	103	105	103	104	103	103	103	103	103	104	108	119	119	118	132	155	158	158	198	234

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings